![](/img/cover-not-exists.png)
PRE-clinical investigation of AT7519, a novel CDK inhibitor, as a potential therapeutic agent in pancreatic cancer
Thomas, A., Shaw, E., Ghaneh, P., Greenhalf, W., Davies, M., Costello, E., Gibbs, F., Lyons, J., Sibson, D.R., Neoptolemos, J.P.Volume:
12
Language:
english
Journal:
Pancreatology
DOI:
10.1016/j.pan.2012.03.023
Date:
May, 2012
File:
PDF, 45 KB
english, 2012